Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Cardiology

RSS  

Articles

  • Pharmacology Watch: Rifamixin for the Prevention of Traveler’s Diarrhea?

    Rifamixin, a nonabsorbed oral antibiotic, is effective for preventing traveler's diarrhea, according to new research.
  • Ablation vs Antiarrhythmic for Symptomatic Atrial Fibrillation

    By John P. DiMarco, MD, PhD Professor of Medicine, Division of Cardiology, University of Virginia, Charlottesville Dr. DiMarco is a consultant for Novartis and does research for Medtronic and Guidant. Synopsis: Pulmonary vein isolation is a feasible first-line approach for this treatment of selected patients with symptomatic atrial fibrillation. Source: Wazni OM, et.al. Radiofrequency Ablation vs Antiarrhthymic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial. JAMA. 2005; 293:2634-2640.
  • Four-Year Invasive Follow-Up of Drug-Eluting Stents

    Professor of Medicine, Chief of Clinical Cardiology, University of California, San Francisco Synopsis: The beneficial effects of drug-eluting stents on coronary artery lumen enhancement are preserved for 4 years after implantation. Source: Sousa JE, et al. Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated with Sirolimus-Eluting Stents. Circulation. 2005:111:2326-29.
  • Full July 2005 Issue in PDF

  • BNP in Mitral Regurgitation

    By Michael H. Crawford, MD Synopsis: Higher BNP levels predict worse outcomes under medical management and may be useful for decisions regarding surgery. Source: Detaint D, et al. B-Type Natriuretic Peptide in Organic Mitral Regurgitation. Circulation. 2005;111:2391-2397.
  • The Gender Specific Impact of Diabetes and Myocardial Infarction at Baseline and During Follow-Up on Mortality From All Causes and Coronary Heart Disease

    By Jonathan Abrams, MD Professor of Medicine, Division of Cardiology, University of New Mexico, Albuquerque Dr. Abrams serves on the speakers bureau for Merck, Pfizer, and Parke-Davis. Synopsis: In order to reduce CVD mortality, more active management and prevention of diabetes is needed. Source: Hu G, et al. The Gender-Specific Impact of Diabetes and Myocardial Infarction at Baseline and During Follow-Up on Mortality From All Causes and Coronary Heart Disease. J Am Coll Cardiol. 2005;45:1413-1418.
  • Heart Rate Profile During Exercise as a Predictor of Sudden Death

    By John P. DiMarco, MD, PhD Synopsis: Data are consistent with the concept that autonomic imbalance predisposes persons to life-threatening arrhythmias. Source: Jouven X, et.al. Heart-Rate Profile During Exercise as a Predictor of Sudden Death. N Engl J Med. 2005;352:1951-1958.
  • Severe Tricuspid Regurgitation Post Device Placement

    By Michael H. Crawford, MD Synopsis: Damage to the tricuspid valve caused by electrophysiologic device leads may be a cause of predominant right heart failure due to severe TR and may not be recognized on routine echocardiography. Source: Lin G, et al. Severe Symptomatic Tricuspid Valve Regurgitation Due to Permanent Pacemaker or Implantable Cardioverter-Defibrillator Leads. J Am Coll Cardiol. 2005; 45:1672-1675.
  • Full August 8, 2005, Issue in PDF

  • Management of the Difficult Airway

    Difficult airway is a broad term that unfortunately encompasses many clinical situations and their potential management options. Airway management difficulties can be divided into those that are predicted and those that are unexpected. They also can require immediate attention (emergent) or be stable (non-emergent). Difficulty can arise at any stage of airway management. Development of a standardized airway assessment and approach to management allows the physician to provide better patient care. Optimal care requires skill in assessing the situation, knowledge of equipment, and finally, how to use it successfully.